Oslo, Norway, 28 April 2021
Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual
General Meeting in Vistin Pharma, to be held on 20 May at 13:00 CEST. Due to the
Covid-19 situation, a physical Annual General Meeting cannot be held. Instead,
shareholders should authorize the Chairman of the Board. It is possible to give
proxy with and without voting instructions. By using a proxy with voting
instructions, the shareholders will vote on the specific issues without personal
attendance. For further information on the use of proxy, see general information
at the bottom of the notice and enclosed proxy forms.
The recommendation from the Election Committee is available on the Company's
website. The formal call will be sent to all shareholders registered in the
Norwegian Central Security Depository (VPS) and are also attached to this
announcement.
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)
This information is subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.